1. CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia–reperfusion injury in vivo and in vitro
- Author
-
Xiaojie Pan, Pengjie Tu, Yangyun Huang, Wenshu Chen, Yun Ding, and Yiyong Chen
- Subjects
Epoxygenase ,Male ,Hypertension, Pulmonary ,Pharmacology ,Lung injury ,medicine.disease_cause ,Pulmonary arterial hypertension ,Cytochrome P-450 CYP2J2 ,CYP2J2 ,Diseases of the respiratory system ,8,11,14-Eicosatrienoic Acid ,medicine ,Animals ,Humans ,PI3K/AKT/mTOR pathway ,Cells, Cultured ,biology ,RC705-779 ,Chemistry ,Research ,medicine.disease ,Rats ,Disease Models, Animal ,Gene Expression Regulation ,Lung ischemia–reperfusion injury ,Apoptosis ,Reperfusion Injury ,biology.protein ,RNA ,Tumor necrosis factor alpha ,EETs ,Reperfusion injury ,Oxidative stress - Abstract
Background Cytochrome P450 epoxygenase 2J2 (CYP2J2) metabolizes arachidonic acid to epoxyeicosatrienoic acids (EETs), which exert anti-inflammatory, anti-apoptotic, pro-proliferative, and antioxidant effects on the cardiovascular system. However, the role of CYP2J2 and EETs in pulmonary arterial hypertension (PAH) with lung ischemia–reperfusion injury (LIRI) remains unclear. In the present study, we investigated the effects of CYP2J2 overexpression and exogenous EETs on PAH with LIRI in vitro and in vivo. Methods CYP2J2 gene was transfected into rat lung tissue by recombinant adeno-associated virus (rAAV) to increase the levels of EETs in serum and lung tissue. A rat model of PAH with LIRI was constructed by intraperitoneal injection of monocrotaline (50 mg/kg) for 4 weeks, followed by clamping of the left pulmonary hilum for 1 h and reperfusion for 2 h. In addition, we established a cellular model of human pulmonary artery endothelial cells (HPAECs) with TNF-α combined with anoxia/reoxygenation (anoxia for 8 h and reoxygenation for 16 h) to determine the effect and mechanism of exogenous EETs. Results CYP2J2 overexpression significantly reduced the inflammatory response, oxidative stress and apoptosis associated with lung injury in PAH with LIRI. In addition, exogenous EETs suppressed inflammatory response and reduced intracellular reactive oxygen species (ROS) production and inhibited apoptosis in a tumor necrosis factor alpha (TNF-α) combined hypoxia-reoxygenation model of HPAECs. Our further studies revealed that the anti-inflammatory effects of CYP2J2 overexpression and EETs might be mediated by the activation of PPARγ; the anti-apoptotic effects might be mediated by the PI3K/AKT pathway. Conclusions CYP2J2 overexpression and EETs protect against PAH with LIRI via anti-inflammation, anti-oxidative stress and anti-apoptosis, suggesting that increased levels of EETs may be a promising strategy for the prevention and treatment of PAH with LIRI. Graphical Abstract
- Published
- 2021